In vitro functional test of two subclasses of an anti-RhD antibody produced by transient expression in COS cells

APMIS

Volumn 114, Issue 5, 2006, Pages 345-351

  Nielsen, Leif Kofoed ^a,c   Norderhaug, Lars ^b   Sandlie, Inger ^b   Dziegiel, Morten Hanefeld ^a  

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF OSLO   (Norway)

^c Rigshospitalet   (Denmark)

Author keywords

Erythrocyte; Eukaryotic expression; Recombinant antibody; RhD

Indexed keywords

IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G3 ANTIBODY; PLASMID VECTOR; RECOMBINANT ANTIBODY; RHESUS D ANTIBODY; RHESUS D ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DNA SEQUENCE; FUNCTION TEST; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RESPIRATORY BURST;

ANIMALS; ANTIBODY SPECIFICITY; CERCOPITHECUS AETHIOPS; CHEMILUMINESCENT MEASUREMENTS; COS CELLS; ERYTHROBLASTOSIS, FETAL; HUMANS; IMMUNOGLOBULIN G; PEPTIDES; PLASMIDS; PROTEIN ENGINEERING; RECOMBINANT PROTEINS; RESPIRATORY BURST; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN; TRANSFECTION;

EID: 33744820821     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2006.apm_381.x     Document Type: Article

References (27)

1. Kumpel BM Goodrick MJ Pamphilon DH Fraser ID Poole GD Morse C, et al. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D-volunteers. Blood 1995 86:1701 9.
2. Williamson RA Persson MA Burton DR. Expression of a human monoclonal anti-(rhesus D) Fab fragment in Escherichia coli with the use of bacteriophage lambda vectors. Biochem J 1991 277 Pt 2 561 3.
3. Siegel DL Silberstein LE. Expression and characterization of recombinant anti-Rh(D) antibodies on filamentous phage: a model system for isolating human red blood cell antibodies by repertoire cloning. Blood 1994 83:2334 44.
4. Dziegiel M Nielsen LK Andersen PS Blancher A Dickmeiss E Engberg J. Phage display used for gene cloning of human recombinant antibody against the erythrocyte surface antigen, rhesus D. J Immunol Methods 1995 182:7 19.
5. Marks JD Ouwehand WH Bye JM Finnern R Gorick BD Voak D, et al. Human antibody fragments specific for human blood group antigens from a phage display library. Biotechnology (N.Y.) 1993 11:1145 9.
6. Siegel DL Chang TY Russell SL Bunya VY. Isolation of cell surface-specific human monoclonal antibodies using phage display and magnetically-activated cell sorting: applications in immunohematology. J Immunol Methods 1997 206:73 85.
7. Miescher S Vogel M Biaggi C Ramseyer V Hustinx H Eicher N, et al. Sequence and specificity analysis of recombinant human Fab anti-Rh D isolated by phage display. Vox Sang 1998 75:278 87.
8. Heyman B. The immune complex: possible ways of regulating the antibody response. Immunol Today 1990 11:310 3.
9. Leader KA Kumpel BM Hadley AG Bradley BA. Functional interactions of aglycosylated monoclonal anti-D with Fc gamma RI+ and Fc gamma RIII+ cells. Immunology 1991 72:481 5.
10. Bouquin T Thomsen M Nielsen LK Green TH Mundy J Dziegiel MH. Human anti-rhesus D IgG1 antibody produced in transgenic plants. Transgenic Res 2002 11:115 22.
11. Klein P Beliard R Glacet A Moitel S Ducrot T Bourel D. Human recombinant anti-Rh(D) monoclonal antibodies: improvement of biological properties by in vitro class-switch. Hum Antibodies 1997 8:17 25.
12. Paterson T Innes J McMillan L Downing I Carter MC. Variation in IgG1 heavy chain allotype does not contribute to differences in biological activity of two human anti-Rhesus (D) monoclonal antibodies. Immunotechnology 1998 4:37 47.
13. Kumpel BM. Monoclonal anti-D development programme. Transpl Immunol 2002 10:199 204.
14. Hadley AG Kumpel BM Leader K Merry AH Brojer E Zupanska B. An in-vitro assessment of the functional activity of monoclonal anti-D. Clin Lab Haematol 1989 11:47 54.
15. Norderhaug L Olafsen T Michaelsen TE Sandlie I. Versatile vectors for transient and stable expression of recombinant antibody molecules in mammalian cells. J Immunol Methods 1997 204:77 87.
16. Dziegiel M Borre MB Jepsen S Hogh B Petersen E Vuust J. Recombinant Plasmodium falciparum glutamate rich protein; purification and use in enzyme-linked immunosorbent assay. Am J Trop Med Hyg 1991 44:306 13.
17. Hadley AG Kumpel BM Merry AH. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies. Clin Lab Haematol 1988 10:377 84.
18. Brekke OH Loset GA. New technologies in therapeutic antibody development. Curr Opin Pharmacol 2003 3:544 50.
19. Kumpel BM Leader KA Merry AH Hadley AG Poole GD Blancher A, et al. Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis. Eur J Immunol 1989 19:2283 8.
20. Ward ES Ghetie V. The effector functions of immunoglobulins: implications for therapy. Ther Immunol 1995 2:77 94.
21. Miescher S Zahn-Zabal M De Jesus M Moudry R Fisch I Vogel M, et al. CHO expression of a novel human recombinant IgG1 anti-RhD antibody isolated by phage display. Br J Haematol 2000 111:157 66.
22. Strachan AJ Williams B Mohabir L Rowe GP. Human Rh monoclonal antibodies: assessment of functional activity by chemiluminescence and RhD antibody quantitation. Transfus Clin Biol 1996 3:483 7.
23. Kumpel BM Hadley AG. Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines. Mol Immunol 1990 27:247 56.
24. Kumpel BM. Functional activity of human Rh monoclonal antibodies (MABS). J Immunogenet 1990 17:321 30.
25. de Lange GG. Allotypes and other epitopes of immunoglobulins. Baillieres Clin Haematol 1991 4:903 25.
26. Siberil S de Romeuf C Bihoreau N Fernandez N Meterreau JL Regenman A, et al. Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory FcgammaR functions. Clin Immunol 2005 Dec 2, [Epub ahead of print].
27. Ludlam CA Turner ML. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products. Br J Haematol 2006 132:13 24.